Researchers Validate In Vivo Imaging Research Method for Studying Drug Efficiency and Disease Progression
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
In a paper published in the online edition of the Journal of Molecular Imaging and Biology (DOI 10.1007/s11307-006-0058-z, 10/12/2006), a team of Mayo Clinic researchers led by Stephanie Carlson, M.D., reported that combined MicroSPECT and micro CT imaging can be used to quantify intratumoral radioisotope uptake in vivo and is more reliable than planar or MicroSPECT imaging alone.
The research team carried out the study using a dual modality MicroSPECT/micro CT in vivo imaging system from Gamma Medica-Ideas.
Using in vivo imaging to collect quantitation data can save drug development and research time and improve the accuracy of pre-clinical research.
